Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT04650243 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Primary Biliary Cholangitis

Interventions

DRUG: ursodeoxycholic acid

Sponsor

Peking Union Medical College Hospital